J Med Libr Assoc. 2022 Apr 1;110(2):185-204. doi: 10.5195/jmla.2022.1306.
Poor indexing and inconsistent use of terms and keywords may prevent efficient retrieval of studies on the patient-based benefit-risk assessment (BRA) of medicines. We aimed to develop and validate an objectively derived content search strategy containing generic search terms that can be adapted for any search for evidence on patient-based BRA of medicines for any therapeutic area.
We used a robust multistep process to develop and validate the content search strategy: (1) we developed a bank of search terms derived from screening studies on patient-based BRA of medicines in various therapeutic areas, (2) we refined the proposed content search strategy through an iterative process of testing sensitivity and precision of search terms, and (3) we validated the final search strategy in PubMed by firstly using multiple sclerosis as a case condition and secondly computing its relative performance versus a published systematic review on patient-based BRA of medicines in rheumatoid arthritis.
We conceptualized a final search strategy to retrieve studies on patient-based BRA containing generic search terms grouped into two domains, namely the patient and the BRA of medicines (sensitivity 84%, specificity 99.4%, precision 20.7%). The relative performance of the content search strategy was 85.7% compared with a search from a published systematic review of patient preferences in the treatment of rheumatoid arthritis. We also developed a more extended filter, with a relative performance of 93.3% when compared with a search from a published systematic review of patient preferences in lung cancer.
索引不佳以及术语和关键词的使用不一致,可能会阻碍对药物基于患者的获益-风险评估(BRA)研究的有效检索。我们旨在开发和验证一种客观得出的包含通用搜索词的内容搜索策略,该策略可适用于针对任何治疗领域的药物基于患者的 BRA 的任何证据检索。
我们使用了一个稳健的多步骤流程来开发和验证内容搜索策略:(1)我们从各种治疗领域的药物基于患者的 BRA 的筛查研究中开发了一个搜索词库,(2)我们通过反复测试搜索词的灵敏度和精度来改进拟议的内容搜索策略,(3)我们首先使用多发性硬化症作为病例条件,在 PubMed 中验证最终搜索策略,其次计算其相对于发表的关于类风湿关节炎药物基于患者的 BRA 的系统评价的相对性能。
我们构思了一种最终的搜索策略,以检索包含通用搜索词的药物基于患者的 BRA 研究,这些搜索词分为两个领域,即患者和药物的 BRA(灵敏度 84%,特异性 99.4%,精度 20.7%)。与发表的关于类风湿关节炎治疗中患者偏好的系统评价的检索相比,内容搜索策略的相对性能为 85.7%。我们还开发了一个更扩展的筛选器,与发表的关于肺癌患者偏好的系统评价的检索相比,其相对性能为 93.3%。